What is Known:    • Somatic symptoms disorders (SSDs) are frequent in the pediatric age, especially in early adolescence.    • Evidence remains scarce on the impact of the SARS-CoV-2 pandemic on SSDs in children.

What is New:    • Children with SSD who accessed during the SARS-CoV-2 pandemic presented specific clinical features.    • The implementation of pediatricians’ education and a multidisciplinary approach are needed to optimize the management of SSDs.